Subject Area and Research Team: V. Cancer imaging
Research topics
1. Assessment of metabolic tumour volume as a predictor of response to treatment in lymphomas
2. Second-generation ultrasound contrast agents as an additional element in the diagnosis and monitoring of treatment response and side effects in paediatric malignancies
3. Diffusion-dependent imaging models, including IVIM (intravoxel incoherent motion) and DKI (diffusion kurtosis imaging) in MRI assessment of large salivary gland tumours
4. Clinical usefulness of quantitative functional MRI parameters in detection, grading and staging of prostate cancer
5.Virtual reality (VR) and augmented reality (AR) in surgery
Coordinators
| Coordinator #1 | Coordinator #2 | |
|---|---|---|
| Name and surname |  |
 |
| Academic degree | Ph.D. | Ph.D. |
| Employment unit | 2nd Department of Radiology | Division of Nuclear Medicine |
| Polish Platform of Medical Research | Karolina Markiet, Ph.D. | Grzegorz Romanowicz, Ph.D. |
| karolina.markiet@gumed.edu.pl | grzegorz.romanowicz@gumed.edu.pl | |
| Phone number | +48 58 349 36 80 | +48 58 584 45 20 |
photo Paweł Sudara/MUG
Research Team: V. Cancer imaging
Team Members: V. Cancer imaging (280 KB)Feel free to contact one of our coordinators to join our Research Team.
Key current projects
1. The role of metabolic tumour volume in patients with early stage Hodgkin lymphoma
2. Evaluation of the cut-off values of IVIM and DKI parameters, that alone and/or in combination with ADC value would increase the diagnostic performance of magnetic resonance of parotid glands
3. Evaluation of the concept of diagnostic imaging algorithm in parotid gland tumours without ad-ministration of contrast medium
4. Value of different models of diffusion imaging (standard monoexponential, stretched exponen-tial, diffusion kurtosis imaging) in detection and grading of prostate cancer
5. Project „CLEARLY – Validation of multiparametric models and circulating and imaging biomarkers to improve lung cancer early detection as a part of „Horizon 2020 – the Framework Programme for Research and Innovation (2014-2020) – ERANET on Translational Cancer Research TRANSCAN-2”. Grant no. ERA-NET TRANSCAN/01/2019
Key grants
| Funding agency/grant number | Title of the project | Years | |
|---|---|---|---|
| 1. | Medical Research Agency/ RAFTING-2019/ 2019/ABM/01/00060 RAFT-ING-2019 | Radiation-Free Therapy for the Initial treat-ment of good prognosis early non-bulky HL, defined by a low Metabolic Tumour Volume and a negative interim PET after 2 chemo-therapy cycles (RAFTING-2019). | 2020-ongoing |
| 2. | Siemens /GUMed/x/1176/08/2019/323 | Prostate AI prototype | 2019-ongoing |
| 3. | Horizon 2020 – the Framework Programme for Research and Innovation (2014-2020) – ERA-NET on Translational Cancer Research TRANSCAN-2. Grant no. ERA-NET TRANS-CAN/01/2019 | CLEARLY – Validation of multiparametric models and circulating and imaging bi-omarkers to improve lung cancer early de-tection | 2018-2020 |
International cooperation
| Foreign partner (unit name) | Principal investigator(s) | Area of cooperation | |
|---|---|---|---|
| 1. | Sapienza, University of Rome | Luciano De Sio | Study on the possibility of applying nanoparticles of gold in medicine |
| 2. | University of Siena | Franco Roviello | Molecular analysis, VR and AR collaboration |
| 3. | Haematology Research and Innovation Department. A. Lacassagne Cancer Centre – Nice, France | Andrea Gallaminii | Research on Hodgkin Lymphoma |
| 4. | International Association for the Study of Lung Cancer (IASLC), Lung Cancer Screen-ing Committee & ELIC Pro-ject, Denver Colorado | Jim Mulshine, Murry Wynes, Ugo Pastorino | Diagnostics and treatment of early lung cancer, lung cancer screening |
Key publications
1. Sidhu Paul S., Cantisani Vito, Deganello Annamaria, Dietrich Christoph F., Duran Carmina, Franke Doris, Harkanyi Zoltan, KOSIAK WOJCIECH, Miele Vittorio, Ntoulia Aikaterini, PISKUNOWICZ MACIEJ, Sellars Maria E., Gilja Odd Helge. Role of contrast-enhanced ultra-sound (CEUS) in paediatric practice: an EFSUMB position statement. Ultraschall Med. 2017; vol. 389: p. 33-43.
2. Mikaszewski B, Markiet K, Smugała A, Stodulski D, Szurowska E, Stankiewicz 4. Diffusion-weighted MRI in the differential diagnosis of parotid malignancies and pleomorphic ade-nomas: can the accuracy of dynamic MRI be enhanced? Oral Surg Oral Med Oral Pathol Oral Radiol. 2017; vol. 124: p. 95-103.
3. Rzyman W, Szurowska E, Adamek M. Implementation of lung cancer screening at the na-tional level: Polish example. Transl Lung Cancer Res 2019; vol. 8: p. 95-105.
4. Nowicki TK, Markiet K, Izycka-Swieszewska E, Dziadziuszko K, Studniarek M, Szurowska E. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the dif-ferential diagnosis of focal nodular hyperplasia: a prospective cohort study. BMC Gastroen-terol. 2018; vol. 18: p. 10.
5. Zaucha JM, Malkowski B, Chauvie S, Subocz E, Tajer J, Kulikowski W ,Fijolek-Warszewska A, Biggi A, Fallanca F, Kobylecka M, Dziuk M, Woszczyk D , Rybka J, Kroll-Balcerzak R, Bergesio F, Romanowicz A, Chamier-Cieminska A, Kurczab P, Giza A, Lesniewski-Kmak K, Zaucha R, Swietlik D, Wróbel T, Knopinska-Posluszny W , Walewski J, Gallamini A. The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin’s lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational Study. Ann Oncol. 2017; vol. 28: p. 3051-3057.